Error: Could not add to watchlist. X
+ Watchlist

Geron Corp

GERN:GR
Ticker Change
GERN:GR has changed to a new ticker symbol
EUR
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
+0.41%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, and in hematologic myeloid malignancies.
Address
149 Commonwealth Drive
Suite 2070
Menlo Park, CA 94025
United States
Phone
1-650-473-7700
Show More